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SUMMARY – Cardiac surgery-associated acute kidney injury (CS-AKI) is a major complication 
associated with increased morbidity and mortality. There are multiple diagnostic criteria for CS-AKI. 
Despite many new investigations available for improved AKI diagnostics, creatinine and urea remain 
the cornerstone of diagnostics in everyday clinical practice. There are three major pathophysiological 
mechanisms that contribute to kidney injury, i.e. renal hypoperfusion, inflammation with oxidative 
stress, and use of nephrotoxic agents. Some risk factors have been identified that can be modified dur-
ing the course of treatment (use of nephrotoxic agents, duration of cardiopulmonary bypass, type of 
extracorporeal circulation, postoperative low cardiac output or hypotension). The aim of AKI preven-
tion should always be to prevent aggravation of renal failure and, if possible, to avoid progression to 
renal replacement therapy, which in turn brings worse long-term outcomes.
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Introduction
Acute kidney injury (AKI) is one of the most prev-
alent major complications following open-heart sur-
gery1. Its incidence ranges from 5% to 42%, depending 
on diagnostic criteria and population studied2. It is 
clinically important because of higher perioperative 
mortality (up to 3- to 8-fold), prolonged intensive care 
unit (ICU) stay, and increased costs3-5. Even subtle de-
crease in renal function could potentially be associated 
with increased mortality, especially after previous per-
cutaneous coronary interventions6. In the ICU, AKI 
after cardiac surgery (CS-AKI) represents the second 
most common cause of all-cause AKI, just after sepsis7. 
CS-AKI is a type 1 representative of the ‘cardiorenal 
syndrome’, a condition in which acute failure of one 
organ deteriorates the function of another one. Clas-
sification of cardiorenal syndrome has been proposed 
by Ronco et al. in 2008 and has five types (Table 1)8.
Diagnostic Criteria
There are over 30 AKI definitions found in the lit-
erature; however, clinically the most widely used clas-
sifications are the following:
-  Risk, Injury, Failure, Loss of kidney function and 
End-stage renal failure (RIFLE)9;
-  Acute Kidney Injury Network (AKIN)10; and
-  Kidney Disease: Improving Global Outcomes 
(KDIGO)11 (Table 2).
Although numerous new biomarkers (cystatin C, 
neutrophil gelatinase-associated lipocalin, interleukins 
6 and 18, kidney injury molecule-1, liver-type fatty 
acid binding protein, N-acetyl-β-D-glucosaminidase, 
α1 microglobulin, glutathione transferase-π, tissue in-
hibitor of metalloproteinase 2, insulin-like growth 
factor-binding protein 7)13-15 have been investigated 
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for more accurate AKI diagnosis, the most frequently 
used and recommended by the Acute Disease Quality 
Initiative (ADQI) Group still are creatinine and urea16.
Creatinine is a metabolic product of creatine phos-
phate breakdown in the skeletal muscle metabolism. 
Its usefulness comes from a relatively constant secre-
tion rate through glomerular filtration, whereas on the 
other hand, none of it is reabsorbed. The main disad-
vantage is its dependence on muscle mass (more sub-
strate for phosphorylation through creatine kinase), 
muscular rhabdomyolysis or medication intake (ci-
metidine, trimethoprim-sulfamethoxazole or proben-
ecid)17. Blood tests for creatinine are significantly 
cheaper compared to other biomarkers listed above.
Urea is one of the nitrogen metabolism products, 
which is formed mainly from amino acids. Urea trans-
ports nitrogen and thus creates osmotic gradient for 
water reabsorption in the loop of Henle. Its main dis-
advantage is responding to external kidney unrelated 
factors such as weight loss (increased proteolysis, more 
amino acids, more nitrogen) and dehydration (exces-
sive need for water reabsorption)18.
Pathophysiology
The mechanisms that influence CS-AKI are not 
yet fully understood. They could be distinguished into 
three major groups, as follows:
Table 2. Comparison of acute kidney injury classifications12
RIFLE AKIN KDIGO
Criterion Creatinine definition Criterion Creatinine definition Criterion Creatinine definition
Risk ≥1.5-fold baseline  
SCr increase or ≥25% 
GFR decrease
Stage 1 ≥1.5-fold or ≥26.5 
µmol/L baseline SCr 
increase within 48 h
Stage 1 ≥1.5-fold baseline SCr 
increase within 7 d or 
≥26.5 µmol/L within 48 h
Injury ≥2-fold baseline  
SCr increase or ≥50% 
GFR decrease
Stage 2 ≥2-fold baseline  
SCr increase
Stage 2 ≥2-fold baseline SCr 
increase within 7 d
Failure ≥3-fold baseline  
SCr increase or ≥75% 
GFR decrease or  
SCr ≥353.6 µmol/L
Stage 3 ≥3-fold or ≥44.2 
µmol/L baseline  
SCr increase or RRT 
initiation
Stage 3 ≥3-fold baseline SCr 
increase within 7 d or SCr 
≥353.6 µmol/L or RRT 
initiation
Loss RRT >4 weeks
End stage RRT >3 months
SCr = serum creatinine; GFR = glomerular filtration rate; RIFLE = Risk, Injury, Failure, Loss of kidney function and End-stage renal 
failure; AKIN = Acute Kidney Injury Network; KDIGO = Kidney Disease: Improving Global Outcomes; RRT = renal replacement 
therapy
Table 1. Cardiorenal syndrome8
Type Inciting event Secondary disturbance Example
Type 1 Rapid worsening of cardiac 
function
Acute kidney injury Acute cardiogenic shock or acute 
decompensation
Type 2 Chronic abnormalities in cardiac 
function
Progressive chronic kidney injury Chronic heart failure
Type 3 Abrupt worsening of kidney 
function
Acute heart failure or arrhythmia Acute kidney injury
Type 4 Chronic kidney disease Decreased cardiac function, 
ventricular hypertrophy
Chronic glomerular disease
Type 5 Acute or chronic systemic 
disorder
Combined cardiac and renal 
dysfunction
Diabetes mellitus, sepsis, 
vasculitis, sarcoidosis
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•	 renal hypoperfusion (prerenal AKI);
•	 inflammation and oxidative stress (renal AKI); 
and
•	 nephrotoxic medications and agents (renal 
AKI)19,20.
Renal hypoperfusion
Renal hypoperfusion is the consequence of non-
pulsatile low-flow circulation state during surgery 
maintained by extracorporeal circulation (ECC). In 
addition, fast temperature changes are observed during 
surgery, which in turn affect renal flow. The latter could 
also be compromised by excessive intraoperative bleed-
ing. Open-heart procedures often present a state of 
unstable cardiac output, and since the kidneys take up 
to 20% of cardiac output, any decrease in cardiac out-
put (either through increased resistance or decreased 
pressure gradient) will eventually compromise renal 
flow. Prolonged kidney ischemia leads to acute tubular 
necrosis, since the proximal tubule is one of the most 
metabolically active tissues and consequently sensitive 
to oxygen deprivation. After ECC termination, isch-
emia-reperfusion injury (IRI) can decrease cellular en-
ergy storage with direct mitochondrial damage and 
oxidative phosphorylation reduction. On the other 
hand, IRI causes massive influx of reactive oxygen spe-
cies (ROS). Intravascular hemolysis occurs after blood 
contacting artificial surfaces in the ECC circuit, thus 
liberating hemoglobin, which leads to nitric oxide sup-
pression, afferent arterial vasoconstriction, and in-
creased heme oxygenase 1 expression21.
Inflammation and oxidative stress
Surgical tissue injury and blood exposure to artifi-
cial materials coupled with blood transfusions cause 
massive inflammatory cell accumulation and comple-
ment activation. The main factor in ROS creation is 
the iron accumulated from hemoglobin release. It af-
fects renal cell proliferation via lipid peroxidation and/
or protein oxidation22.
Nephrotoxic medications and agents
Kidney function is also affected by various xenobi-
otics, frequently used pre-, intra- and postoperatively. 
The main groups are antibiotics (glycopeptides, ami-
noglycosides), nonsteroidal anti-inflammatory drugs 
and antihypertensive drugs (angiotensin-converting 
enzyme inhibitors, angiotensin receptor blockers). 
Major impact of contrast dye (used in many diagnostic 
procedures) on kidney injury has been proven, as it is 
used for some diagnostic procedures (coronary angi-
ography, computed tomography). A response via the 
sympathetic nervous system is triggered, resulting in 
renin-angiotensin-aldosterone axis activation and in-
creased vasopressin and endothelin production, all 
leading to afferent arterial vasoconstriction and dimin-
ished renal flow. In patients with infective endocardi-
tis, septic emboli are frequent, which can also lead to 
tubular necrosis. A similar effect can be observed after 
cholesterol emboli due to extensive aortic manipula-
tion23.
Regardless of the mechanism, CS-AKI can also be 
classified according to the onset timing into early AKI 
(in the first seven days after surgery) and late AKI (in 
more than seven days after surgery, most frequently 
after cardiogenic shock)20.
Acute Kidney Injury Risk Factors
Wang and Bellomo have divided risk factors by their 
relevance at different times with respect to the cardiac 
surgery procedure20. Preoperative risk factors include fe-
male sex, advanced age, pre-existing comorbidities 
(chronic kidney disease (CKD), previous cardiac sur-
gery, diabetes mellitus (DM), chronic obstructive pul-
monary disease, arterial hypertension, hypercholesterol-
emia, congestive heart failure, left ventricular ejection 
fraction <35%, and obesity)24. Intraoperative factors in-
clude use of nephrotoxic medications, emergency sur-
gery, cardiopulmonary bypass (CPB) time, and com-
plexity of surgery25. Postoperative risk factors include 
postoperative hypotension/cardiogenic shock, low he-
matocrit (<24%), and need for blood transfusion26.
However, risk factors could also be classified ac-
cording to the possible impact they could have in order 
to prevent CS-AKI. The non-modifiable factors are 
female sex, advanced age, pre-existing comorbidities, 
emergency surgery, and complexity of surgery. The fac-
tors that could be at least potentially influenced are 
preoperative obesity in patients undergoing elective 
procedures, nephrotoxic substance use, CPB time, 
cross-clamp time, non-pulsatile flow, and intraopera-
tive or postoperative bleeding.
The role of CPB is still controversial. There have 
been only three randomized controlled trials compar-
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ing on-pump versus off-pump coronary artery bypass 
grafting (CABG) surgeries. The CORONARY trial 
was conducted on 4752 patients in 79 centers world-
wide, who were randomly assigned to off-pump or on-
pump CABG. At one year after surgery, no reduction 
in mortality, myocardial infarction, stroke or new renal 
failure requiring renal replacement therapy (RRT) was 
observed27. The ROOBY trial enrolled 2203 patients 
in 18 centers, who were randomly chosen for either 
off-pump or on-pump CABG. Interestingly, some dif-
ferences proved to be statistically significant in periop-
erative data, such as residents being the ‘primary sur-
geons’ (p<0.001), conversion to other treatment 
(p<0.001), duration of surgery (p=0.05), number of 
grafts performed, and ratio between the number of 
planned and performed grafts (p<0.001), all in favor of 
on-pump CABG. There were no differences regarding 
renal failure at 30-day follow-up, including renal fail-
ure requiring RRT. Unfortunately, no data on renal 
function after one year are reported28. In the HEP-
CON trial, which included 120 patients, Deininger et 
al. compared three different types of CPB, i.e. conven-
tional CPB, minimally invasive CPB, and off-pump 
CABG. Temporary superiority of minimally invasive 
CPB and off-pump surgery was recorded in regard to 
acute tubular necrosis via free hemoglobin measure-
ment (p<0.001), but with no significant long-term dif-
ferences29.
Prediction
The ADQI Group recommends routine imple-
mentation of risk-prediction models for all cardiac 
surgical procedures, using estimated glomerular filtra-
tion rate (eGFR), cystatin C or albuminuria to predict 
postoperative AKI16. The Cleveland Clinic Score, the 
Mehta Score and the Simplified Renal Index score are 
all validated scores in predicting AKI, especially severe 
AKI prone to RRT30-32. Of all the predicting scores for 
severe AKI, the Cleveland Clinic Score is most widely 
tested and showed high discrimination in the tested 
cohorts33. Birnie et al. developed a KDIGO-based 
score to predict AKI of all stages, not only severe AKI. 
The following independent risk factors for developing 
end-stage AKI have been identified: age >75 years, fe-
male sex, body mass index (BMI) >35, active smoking 
status, New York Heart Association (NYHA) class 4, 
preoperative DM, arterial hypertension, and GFR >90 
mL/min34. Taking into account the high risk of AKI 
development, using the Reynolds Risk Score can pre-
dict the overall cardiovascular risk35.
Prevention and Therapy
There are some useful principles for optimal post-
operative patient management, as follows:
•	 low cardiac output avoidance with the use of 
inotropes and blood volume substitution (hema-
tocrit >24%, role of pulsatile CPB is still contro-
versial);
•	 hypotension avoidance with optimal volume 
management and vasopressors (mean arterial 
pressure (MAP) >60 mm Hg, use of balanced 
solutions over 0.9% saline to prevent hyperchlo-
remia;
•	 nephrotoxic agent avoidance; and
•	 glycemic index optimization (blood glucose <6.1 
mmol/L)12,16,20.
Nevertheless, even with optimal management, 
2%-6% of patients develop severe AKI for which 
RRT must be initiated23. RRT initiation criteria are as 
follows:
•	 clinical: anuria ≥6 h or urine output ≤200 mL 
over 12 h or volume overload (pulmonary edema 
unresponsive to diuretics); and
•	 laboratory: hyperkalemia >6.5 mmol/L or meta-
bolic acidosis pH <7.2 or urea >30 mmol/L or 
creatinine >300 µmol/L36.
Many preventive measures were investigated in re-
cent years. Antonic reports no significant reduction in 
CS-AKI using perioperative intravenous antioxidant 
ascorbic acid (p=0.779). However, it was a small, sin-
gle-center study enrolling only 100 elective low-risk 
on-pump CABG patients37. Bailey et al. investigated a 
potential renoprotective effect of urine alkalization us-
ing sodium bicarbonate through decreased comple-
ment activation and prevention of tubular hemoglobin 
cast formation. Performing a meta-analysis on 877 
patients from three double-blind randomized con-
trolled trials, they demonstrated only reduction in se-
vere AKI development and RRT avoidance (p<0.001), 
but no statistical significance was achieved in overall 
AKI (p=0.29)38. Yang et al. proved osmotic agent man-
nitol involvement in renal function decrease in patients 
with contrast-induced nephropathy, with no beneficial 
effects regarding CS-AKI in their meta-analysis con-
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taining 626 patients from nine randomized controlled 
trials (p=0.59)39. Scrascia et al. conducted a meta-anal-
ysis on 931 patients in 14 trials in regards to steroid 
use in cardiac surgery patients in order to modulate 
inflammatory response, but were unsuccessful in prov-
ing its beneficial effect (p=0.79)40. The ADQI Group 
does not recommend levosimendan, statins, and N-
acetylcysteine16.
Minimally Invasive Cardiac Surgery  
and Renal Function
Although the incidence of minimally invasive ap-
proaches for cardiac surgery procedures is increasing, 
literature covering the topic of AKI after these proce-
dures is scarce. A recent study by Vandewiele et al. found 
no important clinical differences in renal function be-
tween minimally invasive cardiac surgery (MICS) and 
conventional median sternotomy with mitral and/or 
tricuspid valve surgery despite longer CPB and aortic 
cross-clamp times in the MICS group41. In the aortic 
valve position, comparison between MICS and trans-
aortic transcatheter aortic valve implantation (TAVI) 
revealed a higher risk of AKI development in the TAVI 
group (p=0.017), with higher preoperative EuroS-
CORE II having no impact on postoperative AKI42. 
Left ventricular assist devices (LVADs) significantly 
improve kidney function with a trend towards better re-
nal outcomes after MICS but with no statistical signifi-
cance due to a small group size43.
Conclusion
Cardiac surgery-associated acute kidney injury re-
mains a serious complication after cardiac surgery with 
a high incidence and clinically important short- and 
long-term consequences, especially in patients requir-
ing RRT. Sixty-day mortality of patients requiring 
RRT after cardiac surgical procedures exceeds 50%44. 
Short-term consequences of CS-AKI are uremia (in-
creased capillary permeability, increased risk of bleed-
ing, altered mental status), electrolyte imbalance (dys-
rhythmias, muscular weakness, altered mental status), 
acid-base imbalance (increased proteolysis, hemody-
namic instability), and volume overload (interstitial 
edema, increased intraabdominal pressure, disturbed 
oxygen diffusion)20,44-47. Long-term consequences of 
CS-AKI are deterioration of pre-existing CKD (with 
a trend towards a higher risk of developing postperi-
cardiotomy syndrome48) with increased hospital read-
mission rate with the Major Adverse Kidney Events 
composite adaptation, consisting of >25% eGFR re-
duction, RRT or death, which could in case of impair-
ment after 90 days meet the criterion for CKD49; in-
creased mortality (Ferreiro et al. proved a transient as-
sociation of CS-AKI with long-term mortality that 
progressively decreases and vanishes five years after 
surgery50); decreased quality of life; and increased risk 
of further cardiovascular events20,44-47.
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Sažetak
AKUTNO BUBREŽNO OŠTEĆENJE NAKON OPERACIJA NA OTVORENOM SRCU
A. Djordjević, S. Šušak, L. Velicki i M. Antonič
Akutno bubrežno oštećenje povezano s kardiokirurgijom (cardiac surgery-associated acute kidney injury, CS-AKI) je zna-
čajna komplikacija s visokim pobolom i smrtnošću. Postoji više dijagnostičkih kriterija za dijagnozu CS-AKI. Usprkos 
mnogim novim istraživanjima, kreatinin i ureja ostaju temelj dijagnostike. Glavni patofiziološki procesi koji doprinose 
 bubrežnom oštećenju su bubrežna hipoperfuzija, upala uzrokovana oksidativnim stresom i bubrežno oštećenje uzrokovano 
upotrebom nefrotoksičnih sredstava. Tijekom terapije može se utjecati na nekoliko čimbenika rizika (upotreba nefrotoksič-
nih sredstava, trajanje kardiopulmonarne premosnice, tip izvantjelesne cirkulacije, smanjeni minutni volumen ili poslijeope-
racijska hipotenzija). Cilj prevencije AKI je spriječiti progresiju bubrežnog oštećenja koje zahtijeva kompleksniju terapiju i 
donosi lošije dugoročne ishode.
Ključne riječi: Bubrežno oštećenje; Kardiokirurgija; Perfuzija; Oksidativni stres; Dijaliza
